In this respect, recent studies revealed that nucleophosmin NPM1 mutation status in AML cells was associated with IXA sensitivity [53,54], indicating that the response to IXA may be genetic context-dependent. The gene discussed is NPM1; the disease is acute myeloid leukemia.